Dr. Arturo Navarro Martin

ACADEMIC STUDIES

  • Graduate of Medicine and Surgery by the University of Valencia (Year 1997-2003).
  • Specialty in Radiotion Oncology. Graduated in Oncology Catalan Institute (ICO) Hospital Duran I Reynals.(Year 2004-2008).
  • Radioactive Facilities Supervisor.
  • Gamma Knife Fellowship in William Beaumont , Detroit. USA . January 2008-December 2008.
  • Postgraduate in Methodology , Design and development of Clinical Trials in Oncology. 2010
    • Module of Good Clinical Practice Hours 10 .1 Credit.
    • Module of General Aspects of Research Methodology in Clinical Trials in Oncology: 40 Hours.
    • Module of Management in Clinical Trials and Economic Management . 1 Credit.
    • Advanced Module in Applied Statistics in Clinical Trials. 1 Credit.
  • Master in Medical Competences: Oncology Module.ECTS credits 60. Finished in July 2013.
  • Phd. project approved for SBRT in Non small Cell Lung Cancer. Feb 2015.

AFILIATIONS

  • ESTRO (European Society for Radiotherapy & Oncology) Member.
  • FALCON Tutor Delineation from European Society of Radiation Oncology.
  • SEOR (Spanish Society of Radiation Oncology) Member.
  • ETOP member (European Thoracic Oncology Platform).
  • IASLC (International Association for the Study of Lung Cancer Member.
  • Coordinator of Spanish Young Group in SEOR during 2009-2011.
  • Teacher in Bonanova School in: Verification Methods in Radiation Oncology.
  • Associate professor in University of Barcelona.
    • Collaborator in:
    • Lung Metastases Protocol.
    • ICO Guideline in Lung Cancer.
    • ICO Guideline in SBRT for Lung Cancer.
    • ICO Guideline Head and Neck tumors.
    • National Guideline for SBRT in Lung Metastases.

EXPERIENCE

  • ONCOLOGY CATALAN INSTITUTE. JANUARY 2009- CURRENT DATA.
  • Specialist in Lung Cancer Area.
  • Specialist in Sterotactic Body Radiation Therapy in Lung and Bone Metastases.
  • Specialist in Head and Neck Tumors.

PUBLICATIONS AND CONTRIBUTIONS

  • Navarro-Martín A, Maitz A, Manders M, Ducharme E, Chen P, Grills I. Gamma knife radiosurgery as a primary treatment option for solitary brain metastases from ovarian carcinoma. Clin Transl Oncol 2009, May;11(5):326-8. (A). FI: 1,14
  • Krishnamurthy S, Navarro-Martín A, Maitz A. Gamma knife radiosurgery for occipital condyle metastasis. Clin Transl Oncol 2009, Sep;11(9):622-4. (A). FI:1,14
  • Navarro Martín A, Maitz A, Grills IS, Bojrab D, Kartush J, Chen PY, et al. Successful treatment of glomus jugulare tumours with gamma knife radiosurgery: Clinical and physical aspects of management and review of the literature. Clin Transl Oncol 2010, Jan;12(1):55-62.(A).FI:1,14
  • Lopes JC, Navarro A, Solé JM, Martínez M, Guedea F. Stereotactic body radiation therapy for spinal metastases. Clin Transl Oncol 2010, Sep;12(9):639-42. A. F.I.: 1,14
  • Moretones Agut C, León D, Navarro A, Santacruz O, Boladeras AM, Macià M, et al. Interobserver variability in target volume delineation in postoperative radiochemotherapy for gastric cancer. A pilot prospective study. Clin Transl Oncol 2012, Feb;14(2):132-7.A. FI:1,276
  • Prado C, Navarro-Martin A, Lucas A, Macia. M, Guedea F. Adyuvant fractionated radiotherapy after resection of intracranial hemangiopericytoma. Reports of Practical Oncology & Radiotherapy 2012, Jul 4;17(4):237-42.A. NO F.I.
  • Navarro A, Cacicedo J. The next generation of radiation oncologists: Challenges and perspectives. Reports of Practical Oncology & Radiotherapy 2012, Sep;17(5):243-5. E. No F.I.
  • Cacicedo J, Navarro A, Alongi F, Gómez de Iturriaga A, Del Hoyo O, Boveda E, et al. The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach. Cancer Treat Rev 2013, Aug 8.R. FI: 6,024
  • De Llobet LI, Baro M, Figueras A, Modolell I, Da Silva MV, Muñoz P, et al. Development and characterization of an isogenic cell line with a radioresistant phenotype. Clin Transl Oncol 2013, Mar;15(3):189-97.A. FI:1,276.
  • Rosales-Pérez S, Cano-Valdez AM, Flores-Balcázar CH, Guedea-Edo F, Lino-Silva LS, Lozano-Borbalas A, et al. Expression of epstein-barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): A clinicopathological study. Arch Med Res 2014, Apr;45(3):229-36. A.F.I: 2,406.
  • Eriksen JG, Salembier C, Rivera S, De Bari B, Berger D, Mantello G, et al. Four years with FALCON - an ESTRO educational project: Achievements and perspectives. Radiother Oncol 2014, Jul;112(1):145-9. A.F.I: 4,857
  • Cacicedo J, Casquero F, Martinez-Indart L, del Hoyo O, Gomez de Iturriaga A, Navarro A, Bilbao P. A prospective analysis of factors that influence weight loss in patients undergoing radiotherapy. Chin J Cancer 2014, Apr;33(4):204-10. Indexed .A.NO F.I.
  • Carvajal C, Navarro-Martin A, Cacicedo J, Ramos R, Guedea F. Stereotactic body radiotherapy for colorectal lung oligometastases: Preliminary single-institution results. JBUON 2015, Mar 1;20(1):158-65. A. F.I: 0,706

AFILIATIONS

  • ESTRO (European Society for Radiotherapy & Oncology) Member.
  • FALCON Tutor Delineation from European Society of Radiation Oncology.
  • SEOR (Spanish Society of Radiation Oncology) Member.
  • ETOP member (European Thoracic Oncology Platform).
  • IASLC (International Association for the Study of Lung Cancer Member.
  • Coordinator of Spanish Young Group in SEOR during 2009-2011.
  • Teacher in Bonanova School in: Verification Methods in Radiation Oncology.
  • Associate professor in University of Barcelona.
    • Collaborator in:
    • Lung Metastases Protocol.
    • ICO Guideline in Lung Cancer.
    • ICO Guideline in SBRT for Lung Cancer.
    • ICO Guideline Head and Neck tumors.
    • National Guideline for SBRT in Lung Metastases.

IDIOMES

  • Spanish
  • Catalan
  • English (First Certificate July 2010).

logos mutuas imor
logos mutuas imor
logos mutuas imor
logos mutuas imor